%0 Journal Article %A I.E. Evangelou %A A.J. du Plessis %A G. Vezina %A R. Noeske %A C. Limperopoulos %T Elucidating Metabolic Maturation in the Healthy Fetal Brain Using 1H-MR Spectroscopy %D 2016 %R 10.3174/ajnr.A4512 %J American Journal of Neuroradiology %P 360-366 %V 37 %N 2 %X BACKGROUND AND PURPOSE: 1H-MRS provides a noninvasive way to study fetal brain maturation at the biochemical level. The purpose of this study was to characterize in vivo metabolic maturation in the healthy fetal brain during the second and third trimester using 1H-MRS.MATERIALS AND METHODS: Healthy pregnant volunteers between 18 and 40 weeks gestational age underwent single voxel 1H-MRS. MR spectra were retrospectively corrected for motion-induced artifacts and quantified using LCModel. Linear regression was used to examine the relationship between absolute metabolite concentrations and ratios of total NAA, Cr, and Cho to total Cho and total Cr and gestational age.RESULTS: Two hundred four spectra were acquired from 129 pregnant women at mean gestational age of 30.63 ± 6 weeks. Total Cho remained relatively stable across the gestational age (r2 = 0.04, P = .01). Both total Cr (r2 = 0.60, P < .0001) as well as total NAA and total NAA to total Cho (r2 = 0.58, P < .0001) increased significantly between 18 and 40 weeks, whereas total NAA to total Cr exhibited a slower increase (r2 = 0.12, P < .0001). Total Cr to total Cho also increased (r2 = 0.53, P < .0001), whereas total Cho to total Cr decreased (r2 = 0.52, P < .0001) with gestational age. The cohort was also stratified into those that underwent MRS in the second and third trimesters and analyzed separately.CONCLUSIONS: We characterized metabolic changes in the normal fetal brain during the second and third trimesters of pregnancy and derived normative metabolic indices. These reference values can be used to study metabolic maturation of the fetal brain in vivo.GAgestational agetChototal Cho (glycerol 3-phosphocholine + phosphocholine)tCrtotal Cr (phosphocreatine + Cr)tNAAtotal NAA (NAA + N-acetyl aspartylglutamate) %U https://www.ajnr.org/content/ajnr/37/2/360.full.pdf